Jiangsu Hualv Biological Technology Co.Ltd. (300970) — Cash Flow Quality Index
Jiangsu Hualv Biological Technology Co.Ltd. (300970) has a Cash Flow Quality Index of 3.13x as of December 2025. Operating cash flow of CN¥345.31 Million exceeds net income of CN¥110.27 Million, indicating high earnings quality where cash backs reported profits. Explore Jiangsu Hualv Biological Technology Co.L cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jiangsu Hualv Biological Technology Co.Ltd. Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Jiangsu Hualv Biological Technology Co.Ltd. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Jiangsu Hualv Biological Technology Co.L (300970) cash conversion ratio.
Annual Cash Flow Quality Index for Jiangsu Hualv Biological Technology Co.Ltd. (2019–2025)
Year-by-year earnings quality comparison for Jiangsu Hualv Biological Technology Co.Ltd..
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.13x | CN¥345.31 Million | CN¥110.27 Million | ▼ -43.0% |
| 2023 | 5.49x | CN¥166.67 Million | CN¥30.35 Million | ▲ +139.0% |
| 2022 | 2.30x | CN¥179.84 Million | CN¥78.25 Million | ▼ -57.1% |
| 2021 | 5.36x | CN¥83.08 Million | CN¥15.50 Million | ▲ +256.6% |
| 2020 | 1.50x | CN¥199.09 Million | CN¥132.50 Million | ▼ -15.3% |
| 2019 | 1.77x | CN¥213.96 Million | CN¥120.67 Million | — |